Quick Listen: Scrip's Five Must-Know Things
Executive Summary
In this week's podcast edition of Five Must-Know Things: the biggest drug launches expected in 2024; Roche’s Pharma CEO talks about growth momentum; 10 pivotal studies to look out for this year; the obesity market now and in future; and what does 2024 hold for transformative technology in biopharma.
Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip's global team, in this podcast version of Five Must-Know Things.
This episode covers insights for the business week ended 2 February 2024, including: the biggest drug launches expected in 2024; Roche Holding AG’s Pharma CEO talks about growth momentum; 10 pivotal studies to look out for this year; the obesity market now and in future; and what does 2024 hold for transformative technology in biopharma.
This and all our other podcasts are available on the Citeline channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
Stories mentioned in this episode:
(Also see "The Biggest Drug Launches Expected In 2024" - Scrip, 30 Jan, 2024.)
(Also see "Pharma CEO Teresa Graham Talks About Roche’s Growth Momentum" - Scrip, 30 Jan, 2024.)
(Also see "10 Pivotal Studies To Look Out For In 2024" - Scrip, 29 Jan, 2024.)
(Also see "Weighty Matters: The Obesity Market Now… And In Years To Come" - Scrip, 26 Jan, 2024.)
(Also see "Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology" - Scrip, 30 Jan, 2024.)